DC
TCRT icon

Deere & Company’s Alaunos Therapeutics TCRT Stock Holding History

Deere & Company’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-140
Closed -$175K – 1179
2015
Q4 		$175K Hold
140
– – 0.01% 864
2015
Q3 		$190K Sell
140
-150
-52% -$248K 0.01% 865
2015
Q2 		$523K Buy
290
+18
+7% +$27.9K 0.03% 625
2015
Q1 		$440K Buy
+272
New +$403K 0.02% 680

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deere & Company's TCRT Position: Q1 2016 in Review

Deere & Company sold out of Alaunos Therapeutics (TCRT) in Q1 2016, closing a stake of 140 shares — an estimated $175K sold.

Deere & Company first reported a position in TCRT in Q1 2015 and held it in 4 quarters. The position peaked at $523K in Q2 2015. 143 funds tracked by Wall St. Rank hold TCRT as of Q1 2016.

  • Deere & Company reported no remaining Alaunos Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 140 Alaunos Therapeutics shares in Q1 2016, an estimated $175K.
  • Deere & Company first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 4 quarters.
  • Deere & Company's Alaunos Therapeutics position peaked at $523K in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.